Ziegler Christoph Samuel bought VRXA

October 20, 2026 · Form 4 insider transaction

Ziegler Christoph Samuel bought 30,000 shares of Veraxa Biotech AG at $1.09 per share, a transaction worth $32.7K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.